In the contrast, Duldulao et al. [38] observed that XPD Lys/Lys genotype was significantly associated with increased toxicity to neoadjuvant chemoradiotherapy in 132 stage II/III rectal cancer patients in the United States. Here, ERCC2 is linked to rectal cancer.